He reviews your medical history, current medications, and what you are hoping to get out of the protocol
The product information for these medications (SmPCs) provides detailed information about their pharmacodynamic properties and associated side effects
We can create a personalized approach to weight loss, integrating various therapies, healthy habits, and GLP-1 medications
Over recent years, GLP-1-receptor-agonists (GLP-1-RA) have gained significant attention not only for their antidiabetic properties but also for their weight reducing effects [3]
Mounjaro is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist licensed in the UK for type 2 diabetes management and, more recently, for chronic weight management in adults with obesity or overweight with weight-related comorbidities